<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><title>Reuters: Health News</title><link>http://www.reuters.com</link><description>Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.</description><language>en-us</language><copyright>All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. © Reuters 2013</copyright><pubDate>Wed, 22 May 2013 16:03:59 GMT</pubDate><lastBuildDate>Wed, 22 May 2013 16:03:59 GMT</lastBuildDate><ttl>5</ttl><image><title>Reuters: Health News</title><url>http://www.reuters.com/resources_v2/images/reuters125.png</url><link>http://www.reuters.com</link></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/reuters/healthNews" /><feedburner:info uri="reuters/healthnews" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2Freuters%2FhealthNews" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2Freuters%2FhealthNews" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.feedburner.com%2Freuters%2FhealthNews" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.feedburner.com/reuters/healthNews" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2Freuters%2FhealthNews" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2Freuters%2FhealthNews" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2Freuters%2FhealthNews" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><item><title>Pfizer to spin off Zoetis stake to shareholders</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/bvWoA4l1sMw/story01.htm</link><description>(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 percent discount.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c413360/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=bvWoA4l1sMw:ZADMfNMHAVc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=bvWoA4l1sMw:ZADMfNMHAVc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=bvWoA4l1sMw:ZADMfNMHAVc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=bvWoA4l1sMw:ZADMfNMHAVc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=bvWoA4l1sMw:ZADMfNMHAVc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/bvWoA4l1sMw" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 15:57:30 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-pfizer-zoetis-idUSBRE94L0JB20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c413360/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Epfizer0Ezoetis0EidUSBRE94L0AJB20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>When it comes to deadly viruses, what's in a name?</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/HfsOUi93bDs/story01.htm</link><description>LONDON (Reuters) - For a pathogen with such a short history, the mysterious new virus killing people in the Middle East and Europe has already had an amazing array of names.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c41335c/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664220013/u/49/f/654207/c/35217/s/2c41335c/kg/342-363/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664220013/u/49/f/654207/c/35217/s/2c41335c/kg/342-363/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664220013/u/49/f/654207/c/35217/s/2c41335c/kg/342-363/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=HfsOUi93bDs:hWsiE0ieCiU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=HfsOUi93bDs:hWsiE0ieCiU:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=HfsOUi93bDs:hWsiE0ieCiU:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=HfsOUi93bDs:hWsiE0ieCiU:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=HfsOUi93bDs:hWsiE0ieCiU:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/HfsOUi93bDs" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 13:58:20 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-coronavirus-name-idUSBRE94L0JE20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c41335c/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Ecoronavirus0Ename0EidUSBRE94L0AJE20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Swiss billionaires buy Merck Serono HQ for biotech campus</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/i8HdzuA-I0A/story01.htm</link><description>ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c424b45/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=i8HdzuA-I0A:J_l8I0p3z80:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=i8HdzuA-I0A:J_l8I0p3z80:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=i8HdzuA-I0A:J_l8I0p3z80:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=i8HdzuA-I0A:J_l8I0p3z80:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=i8HdzuA-I0A:J_l8I0p3z80:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/i8HdzuA-I0A" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 13:53:57 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-merck-bertarelli-biotech-idUSBRE94L0LC20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c424b45/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Emerck0Ebertarelli0Ebiotech0EidUSBRE94L0ALC20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Oncolytics cancer drug meets mid-stage trial goal, shares rise</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/WpwfZN09eYQ/story01.htm</link><description>(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c41bd8e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=WpwfZN09eYQ:A4U9QS3WXZE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=WpwfZN09eYQ:A4U9QS3WXZE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=WpwfZN09eYQ:A4U9QS3WXZE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=WpwfZN09eYQ:A4U9QS3WXZE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=WpwfZN09eYQ:A4U9QS3WXZE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/WpwfZN09eYQ" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 13:46:31 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-oncolytics-cancerdrug-idUSBRE94L0LM20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c41bd8e/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Eoncolytics0Ecancerdrug0EidUSBRE94L0ALM20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>U.S. government taps GlaxoSmithKline for new antibiotics</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/jxyN7byt3WA/story01.htm</link><description>LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c40534e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=jxyN7byt3WA:SCoGvhCGSsc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=jxyN7byt3WA:SCoGvhCGSsc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=jxyN7byt3WA:SCoGvhCGSsc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=jxyN7byt3WA:SCoGvhCGSsc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=jxyN7byt3WA:SCoGvhCGSsc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/jxyN7byt3WA" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 13:30:49 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-glaxosmithkline-usa-antibiotics-idUSBRE94L0FG20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c40534e/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Eglaxosmithkline0Eusa0Eantibiotics0EidUSBRE94L0AFG20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Los Angeles voters OK move to curtail medical marijuana outlets</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/pxN9AzL5svw/story01.htm</link><description>LOS ANGELES (Reuters) - Voters strongly supported a ballot measure to sharply curtail the number of medical marijuana dispensaries permitted to operate in Los Angeles while boosting taxes on the sale of pot for health reasons, election returns early on Wednesday showed.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3f895d/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=pxN9AzL5svw:qmWkDPAvv0o:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=pxN9AzL5svw:qmWkDPAvv0o:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=pxN9AzL5svw:qmWkDPAvv0o:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=pxN9AzL5svw:qmWkDPAvv0o:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=pxN9AzL5svw:qmWkDPAvv0o:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/pxN9AzL5svw" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 10:54:30 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-usa-marijuana-losangeles-idUSBRE94L0EH20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3f895d/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Eusa0Emarijuana0Elosangeles0EidUSBRE94L0AEH20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Immune system cancer drugs tipped to be a $35 billion market</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/ozv_3CuOu1A/story01.htm</link><description>LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3efe3a/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165665281093/u/49/f/654207/c/35217/s/2c3efe3a/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165665281093/u/49/f/654207/c/35217/s/2c3efe3a/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165665281093/u/49/f/654207/c/35217/s/2c3efe3a/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ozv_3CuOu1A:0wmzHbmIXU8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ozv_3CuOu1A:0wmzHbmIXU8:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ozv_3CuOu1A:0wmzHbmIXU8:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ozv_3CuOu1A:0wmzHbmIXU8:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ozv_3CuOu1A:0wmzHbmIXU8:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/ozv_3CuOu1A" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 09:48:42 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-cancer-immunotherapy-idUSBRE94L0CF20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3efe3a/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Ecancer0Eimmunotherapy0EidUSBRE94L0ACF20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Merck signs $5 billion share buyback agreement with Goldman Sachs</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/Jei5okuISMA/story01.htm</link><description>(Reuters) - Merck &amp; Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up shareholder value in face of stiff competition from makers of less-costly generics.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3ae037/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Jei5okuISMA:ga8M624gNQM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Jei5okuISMA:ga8M624gNQM:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Jei5okuISMA:ga8M624gNQM:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Jei5okuISMA:ga8M624gNQM:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Jei5okuISMA:ga8M624gNQM:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/Jei5okuISMA" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 06:07:32 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-merck-sharerepurchase-idUSBRE94L03920130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3ae037/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Emerck0Esharerepurchase0EidUSBRE94L0A3920A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Amag investigates anemia drug after report of death in Switzerland</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/uMNGOmBspz0/story01.htm</link><description>(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3a3ff3/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=uMNGOmBspz0:S7_sQ1kEi18:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=uMNGOmBspz0:S7_sQ1kEi18:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=uMNGOmBspz0:S7_sQ1kEi18:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=uMNGOmBspz0:S7_sQ1kEi18:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=uMNGOmBspz0:S7_sQ1kEi18:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/uMNGOmBspz0" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Wed, 22 May 2013 00:43:19 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/22/us-amag-anemiadrug-idUSBRE94K19Q20130522?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c3a3ff3/l/0L0Sreuters0N0Carticle0C20A130C0A50C220Cus0Eamag0Eanemiadrug0EidUSBRE94K19Q20A130A5220DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Amag says anemia drug caused fatal reaction in Switzerland</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/Cx6EFrv3s8I/story01.htm</link><description>(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c395529/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Cx6EFrv3s8I:LHPCsPzd0F4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Cx6EFrv3s8I:LHPCsPzd0F4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Cx6EFrv3s8I:LHPCsPzd0F4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Cx6EFrv3s8I:LHPCsPzd0F4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Cx6EFrv3s8I:LHPCsPzd0F4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/Cx6EFrv3s8I" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 22:04:34 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-amag-anemiadrug-idUSBRE94K19Q20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c395529/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eamag0Eanemiadrug0EidUSBRE94K19Q20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>China's bird flu outbreak cost $6.5 billion</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/UY8Ma-uio4Q/story01.htm</link><description>GENEVA (Reuters) - The H7N9 virus appears to have been brought under control in China largely due to restrictions at bird markets, but caused some $6.5 billion in losses to the economy, U.N. experts said on Tuesday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c37a4d9/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165665261039/u/49/f/654207/c/35217/s/2c37a4d9/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165665261039/u/49/f/654207/c/35217/s/2c37a4d9/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165665261039/u/49/f/654207/c/35217/s/2c37a4d9/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=UY8Ma-uio4Q:B_8RzNcdOcc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=UY8Ma-uio4Q:B_8RzNcdOcc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=UY8Ma-uio4Q:B_8RzNcdOcc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=UY8Ma-uio4Q:B_8RzNcdOcc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=UY8Ma-uio4Q:B_8RzNcdOcc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/UY8Ma-uio4Q" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 21:14:12 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-birdflu-idUSBRE94K0ZQ20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c37a4d9/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Ebirdflu0EidUSBRE94K0AZQ20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Drowsy young drivers have increased crash risk</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/kBUKK8IKnGI/story01.htm</link><description>NEW YORK (Reuters Health) - Young adult drivers who usually get less than six hours of sleep per night are more likely to crash than those who sleep in, according to a new study from Australia.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c38dde8/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=kBUKK8IKnGI:4M7uPWQpzME:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=kBUKK8IKnGI:4M7uPWQpzME:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=kBUKK8IKnGI:4M7uPWQpzME:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=kBUKK8IKnGI:4M7uPWQpzME:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=kBUKK8IKnGI:4M7uPWQpzME:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/kBUKK8IKnGI" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 20:44:17 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-drowsy-drivers-crash-idUSBRE94K16Q20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c38dde8/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Edrowsy0Edrivers0Ecrash0EidUSBRE94K16Q20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Regeneron, Sanofi asthma drug seen as potential game changer</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/KvV8xIOZibo/story01.htm</link><description>(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said on Tuesday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c341a0e/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=KvV8xIOZibo:aNU6EZNOXzc:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=KvV8xIOZibo:aNU6EZNOXzc:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=KvV8xIOZibo:aNU6EZNOXzc:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=KvV8xIOZibo:aNU6EZNOXzc:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=KvV8xIOZibo:aNU6EZNOXzc:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/KvV8xIOZibo" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 20:37:49 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-regeneron-sanofi-asthma-idUSBRE94K0I020130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c341a0e/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eregeneron0Esanofi0Easthma0EidUSBRE94K0AI0A20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>People choose larger portions of ‘healthy' foods</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/xwPB0ztanHE/story01.htm</link><description>NEW YORK (Reuters Health) - People will choose larger portions of food if they are labeled as being "healthier," even if they have the same number of calories, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c387521/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=xwPB0ztanHE:bgexnNxyw9U:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=xwPB0ztanHE:bgexnNxyw9U:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=xwPB0ztanHE:bgexnNxyw9U:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=xwPB0ztanHE:bgexnNxyw9U:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=xwPB0ztanHE:bgexnNxyw9U:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/xwPB0ztanHE" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 19:13:42 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-choose-larger-portions-of-healthy-foo-idUSBRE94K13820130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c387521/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Echoose0Elarger0Eportions0Eof0Ehealthy0Efoo0EidUSBRE94K13820A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Surgery offers mixed benefits for kids' sleep apnea</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/IZANOw4EdSM/story01.htm</link><description>NEW YORK (Reuters Health) - A new study has confirmed that removing the tonsils and adenoids of children with obstructive sleep apnea can reduce sleepiness and improve the quality of life, but putting off the surgery might not hurt either.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c37cbe8/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664190737/u/49/f/654207/c/35217/s/2c37cbe8/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664190737/u/49/f/654207/c/35217/s/2c37cbe8/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664190737/u/49/f/654207/c/35217/s/2c37cbe8/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=IZANOw4EdSM:coaE3B3tXTE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=IZANOw4EdSM:coaE3B3tXTE:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=IZANOw4EdSM:coaE3B3tXTE:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=IZANOw4EdSM:coaE3B3tXTE:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=IZANOw4EdSM:coaE3B3tXTE:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/IZANOw4EdSM" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 18:18:40 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-surgery-kids-idUSBRE94K10I20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c37cbe8/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Esurgery0Ekids0EidUSBRE94K10AI20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Tunisia announces first death from new coronavirus</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/c-3qLRUqicw/story01.htm</link><description>Tunis (Reuters) - A 66-year-old Tunisian man has died from new coronavirus, a strain of a virus that emerged in the Middle East last year, after a visit to Saudi Arabia, the health ministry said on Tuesday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c36ad97/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=c-3qLRUqicw:vrwvUS7u8ec:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=c-3qLRUqicw:vrwvUS7u8ec:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=c-3qLRUqicw:vrwvUS7u8ec:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=c-3qLRUqicw:vrwvUS7u8ec:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=c-3qLRUqicw:vrwvUS7u8ec:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/c-3qLRUqicw" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 16:24:05 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-tunisia-coronavirus-death-idUSBRE94K0UT20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c36ad97/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Etunisia0Ecoronavirus0Edeath0EidUSBRE94K0AUT20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Schoolmates of suicide victims at higher risk</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/K9fpeUdHF4o/story01.htm</link><description>NEW YORK (Reuters Health) - Teens who have a classmate die of suicide are more likely to consider taking, or attempt to take, their own lives, according to a new study.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c36cc7f/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=K9fpeUdHF4o:n4apnf4ZZag:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=K9fpeUdHF4o:n4apnf4ZZag:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=K9fpeUdHF4o:n4apnf4ZZag:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=K9fpeUdHF4o:n4apnf4ZZag:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=K9fpeUdHF4o:n4apnf4ZZag:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/K9fpeUdHF4o" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 16:12:57 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-schoolmates-of-suicide-victims-at-hig-idUSBRE94K0U620130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c36cc7f/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eschoolmates0Eof0Esuicide0Evictims0Eat0Ehig0EidUSBRE94K0AU620A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Health sites too complex, full of cliches: study</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/_jYroSkFC0c/story01.htm</link><description>NEW YORK (Reuters Health) - The importance of health literacy hit home for Lisa Gualtieri when a Cambodian refugee diagnosed with cancer asked her to act as a patient advocate.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c35ddc4/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664184089/u/49/f/654207/c/35217/s/2c35ddc4/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664184089/u/49/f/654207/c/35217/s/2c35ddc4/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664184089/u/49/f/654207/c/35217/s/2c35ddc4/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_jYroSkFC0c:7cyP464aNgY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_jYroSkFC0c:7cyP464aNgY:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=_jYroSkFC0c:7cyP464aNgY:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=_jYroSkFC0c:7cyP464aNgY:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=_jYroSkFC0c:7cyP464aNgY:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/_jYroSkFC0c" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 14:37:42 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-health-sites-cliches-idUSBRE94K0NP20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c35ddc4/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Ehealth0Esites0Ecliches0EidUSBRE94K0ANP20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>AcelRX post-op pain treatment meets late-stage study goal</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/ikdHUnUbhxk/story01.htm</link><description>(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c341a0d/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ikdHUnUbhxk:pQd3zQptGM0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ikdHUnUbhxk:pQd3zQptGM0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ikdHUnUbhxk:pQd3zQptGM0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ikdHUnUbhxk:pQd3zQptGM0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ikdHUnUbhxk:pQd3zQptGM0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/ikdHUnUbhxk" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 14:17:23 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-acelrx-study-paindevice-idUSBRE94K0HS20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c341a0d/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eacelrx0Estudy0Epaindevice0EidUSBRE94K0AHS20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Analysis: Some Republicans see new scandal in Sebelius fundraising</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/cFqdOe9BKY4/story01.htm</link><description>WASHINGTON (Reuters) - With the White House already reeling from three major controversies, some Republican lawmakers are zeroing in on what they perceive is another possible scandal tied to President Barack Obama's landmark health reform law just as it nears implementation.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2e8714/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=cFqdOe9BKY4:AzyAuf5kHpA:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=cFqdOe9BKY4:AzyAuf5kHpA:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=cFqdOe9BKY4:AzyAuf5kHpA:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=cFqdOe9BKY4:AzyAuf5kHpA:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=cFqdOe9BKY4:AzyAuf5kHpA:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/cFqdOe9BKY4" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 08:06:13 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-usa-healthcare-scandals-analysis-idUSBRE94K08420130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2e8714/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eusa0Ehealthcare0Escandals0Eanalysis0EidUSBRE94K0A8420A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Intercell vaccine gets U.S. pediatric approval</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/Ge9BH4gfKn0/story01.htm</link><description>VIENNA (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for pediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it had achieved in Europe in February.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c303656/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664355267/u/49/f/654207/c/35217/s/2c303656/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664355267/u/49/f/654207/c/35217/s/2c303656/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664355267/u/49/f/654207/c/35217/s/2c303656/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Ge9BH4gfKn0:EIt11KNQkJg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Ge9BH4gfKn0:EIt11KNQkJg:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Ge9BH4gfKn0:EIt11KNQkJg:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=Ge9BH4gfKn0:EIt11KNQkJg:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=Ge9BH4gfKn0:EIt11KNQkJg:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/Ge9BH4gfKn0" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 06:47:06 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-intercell-us-idUSBRE94K0A320130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c303656/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eintercell0Eus0EidUSBRE94K0AA320A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Healthcare workers set to strike California public hospitals</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/mExuZp8E1EM/story01.htm</link><description>SAN FRANCISCO (Reuters) - Nearly 13,000 healthcare employees at five University of California medical centers plan to strike on Tuesday in a move that threatens to back up emergency rooms and already has forced the postponement of elective surgeries.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2e53e6/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=mExuZp8E1EM:KK_DdFiqhdI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=mExuZp8E1EM:KK_DdFiqhdI:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=mExuZp8E1EM:KK_DdFiqhdI:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=mExuZp8E1EM:KK_DdFiqhdI:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=mExuZp8E1EM:KK_DdFiqhdI:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/mExuZp8E1EM" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Tue, 21 May 2013 03:11:29 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/21/us-usa-health-strike-idUSBRE94K05O20130521?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2e53e6/l/0L0Sreuters0N0Carticle0C20A130C0A50C210Cus0Eusa0Ehealth0Estrike0EidUSBRE94K0A5O20A130A5210DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>UK first in EU to get Merck's new Schmallenberg vaccine</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/8PCtczc9s0A/story01.htm</link><description>LONDON (Reuters) - British farmers will be the first in Europe to get a vaccine against Schmallenberg virus, a new livestock disease that hit the continent in 2011.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2d1892/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=8PCtczc9s0A:PMG3RezEKjQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=8PCtczc9s0A:PMG3RezEKjQ:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=8PCtczc9s0A:PMG3RezEKjQ:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=8PCtczc9s0A:PMG3RezEKjQ:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=8PCtczc9s0A:PMG3RezEKjQ:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/8PCtczc9s0A" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Mon, 20 May 2013 23:05:41 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/20/us-merck-schmallenberg-idUSBRE94J0Y020130520?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2d1892/l/0L0Sreuters0N0Carticle0C20A130C0A50C20A0Cus0Emerck0Eschmallenberg0EidUSBRE94J0AY0A20A130A520A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Pfizer halts study of lymphoma drug unlikely to help survival</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/EbqrkO1jLzY/story01.htm</link><description>(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not likely to improve survival.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2c29ed/mf.gif' border='0'/&gt;&lt;br/&gt;&lt;br/&gt;&lt;a href="http://da.feedsportal.com/r/165664250724/u/49/f/654207/c/35217/s/2c2c29ed/a2.htm"&gt;&lt;img src="http://da.feedsportal.com/r/165664250724/u/49/f/654207/c/35217/s/2c2c29ed/a2.img" border="0"/&gt;&lt;/a&gt;&lt;img width="1" height="1" src="http://pi.feedsportal.com/r/165664250724/u/49/f/654207/c/35217/s/2c2c29ed/a2t.img" border="0"/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=EbqrkO1jLzY:k7lCM-2C4g0:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=EbqrkO1jLzY:k7lCM-2C4g0:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=EbqrkO1jLzY:k7lCM-2C4g0:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=EbqrkO1jLzY:k7lCM-2C4g0:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=EbqrkO1jLzY:k7lCM-2C4g0:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/EbqrkO1jLzY" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Mon, 20 May 2013 21:57:41 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/20/us-pfizer-cancer-idUSBRE94J0VD20130520?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2c29ed/l/0L0Sreuters0N0Carticle0C20A130C0A50C20A0Cus0Epfizer0Ecancer0EidUSBRE94J0AVD20A130A520A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item><item><title>Swine virus confirmed in Iowa, Indiana hog herds</title><link>http://feedproxy.google.com/~r/reuters/healthNews/~3/ab4V4c7yOvo/story01.htm</link><description>(Reuters) - Farms in two of the nation's leading pork producing states have tested positive for the potentially fatal porcine epidemic diarrhea virus (PEDV), U.S. pork industry veterinarian official said Monday.&lt;img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2c5e89/mf.gif' border='0'/&gt;&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ab4V4c7yOvo:5PZr0V6OsI4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ab4V4c7yOvo:5PZr0V6OsI4:F7zBnMyn0Lo"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ab4V4c7yOvo:5PZr0V6OsI4:F7zBnMyn0Lo" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/reuters/healthNews?a=ab4V4c7yOvo:5PZr0V6OsI4:V_sGLiPBpWU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=ab4V4c7yOvo:5PZr0V6OsI4:V_sGLiPBpWU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/ab4V4c7yOvo" height="1" width="1"/&gt;</description><category domain="">healthNews</category><pubDate>Mon, 20 May 2013 21:33:12 GMT</pubDate><guid isPermaLink="false">http://www.reuters.com/article/2013/05/20/us-usa-hogs-virus-idUSBRE94J0UT20130520?feedType=RSS&amp;feedName=healthNews</guid><feedburner:origLink>http://reuters.us.feedsportal.com/c/35217/f/654207/s/2c2c5e89/l/0L0Sreuters0N0Carticle0C20A130C0A50C20A0Cus0Eusa0Ehogs0Evirus0EidUSBRE94J0AUT20A130A520A0DfeedType0FRSS0GfeedName0FhealthNews/story01.htm</feedburner:origLink></item></channel></rss>
